In recurrent prostate cancer, the expression of DAB2IP is inversely correlated with androgen receptor activation, and DAB2IP expression in PCa cells can suppress androgen-induced cell proliferation and gene activation [28]. The gene discussed is DAB2IP; the disease is posterior cortical atrophy.